PDCD1 and small cell lung carcinoma: Previous studies have shown single-agent anti-PD1 and anti-PD-L1 drugs seem to have little activity in patients with extrapulmonary NECs.41–44 However, single agent-CPI in combination with chemotherapy showed mixed results in GEP-NENs and SCLC.